About This 510(k) Submission
K210946 is an FDA 510(k) clearance for the Promisemed Automatic Biopsy Needles, Promisemed Co-Axial Biopsy Devices, Promisemed Semi-automatic Biopsy Needles, a Instrument, Biopsy (Class II — Special Controls, product code KNW), submitted by Promisemed Hangzhou Meditech Co., Ltd. (Hangzhou City, CN). The FDA issued a Cleared decision on August 12, 2021, 135 days after receiving the submission on March 30, 2021. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 876.1075.